CNR Clinical Physiology Institute, Italy
Resynchronized patients show improved outcome with delay optimization by Doppler-derived LV dP/dt
Published in Cardiovascular Business Week, August 22nd, 2006
According to a study from Italy, "Atrioventricular (AV) interval optimization, ensuring the best filling and the abolishment of presystolic mitral regurgitation, is crucial for the efficacy of cardiac resynchronization therapy (CRT). The methods proposed to optimize AV delay have many limitations."
M.A. Morales and colleagues at the CNR Clinical Physiology Institute in Pisa wrote, "The maximum left ventricular pressure derivative (LV dP/dt) - an index of cardiac performance - could provide a clue for AV optimization....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- Biosite
Biosite notes 45% increase in sales of cardiovascular products - Biovail
Biovail and Athpharma terminate joint development agreement - Cytokinetics
Cytokinetics reports $1.4 million in revenue from R & D collaborations in second quarter - Edwards Lifesciences
Edwards Lifesciences reports strong second quarter earnings - Endologix
Endologix reports continued significant growth during second quarter in U.S. product sales - Finance
Merit Medical reports record Q2 2006 revenues of $48.1 million, up 13.5% over Q2 2005 - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
